Abbott Laboratories said on Monday it and DexCom have reached an agreement to settle all patent disputes between the ...

Abbott (NYSE:ABT) reached an agreement with Dexcom (Nasdaq:DXCM) to settle all outstanding patent disputes between companies.

The Dexcom GenAI platform analyzes individual health data patterns to reveal a direct association between lifestyle choices ...

There has been no shortage of news covered across the diabetes and drug delivery markets over the course of 2024.

Shares of the medical-device maker DexCom (NASDAQ: DXCM) are down by 37% this year. The diabetes-focused healthcare company ...

DexCom (DXCM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

A roundup of health news highlighting the U.S. potential exit from the WHO during Trump's next term, spreading famine in ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

CGMs have saved my life after a heart attack four years ago. I recently tried the Dexcom Stelo OTC CGM, and it's been mighty ...

Chicago, IL – December 23, 2024 – Today, Zacks Investment Ideas feature highlights DexCom, Inc. DXCM and Albemarle ...

Dexcom is bringing generative AI to Stelo users, starting with weekly personalized reports about their glucose ...